InTrOduCTIOn
Cystic fibrosis (CF) is a multisystem genetic disease, which may impact several organ systems. 1 In the lungs, a cycle of persistent inflammation and infection leads to chronic infection, severe airway damage and consequent loss of respiratory function. 2 Thus, CF is characterised by progressive loss of lung function, with obstruction of the airways. 3 Airflow limitation in CF may occur as a result of mucus within the airways and/or airway hyper-reactivity. 4 The result of this obstruction is may be that greater inspiratory airflows require to be generated in order for gas exchange to continue optimally, such that an increase in respiratory muscle effort is required for equivalent minute ventilation (V E ). 5 6 Furthermore, airflow limitation may promote dynamic hyperinflation and lead to increased dead space on exercise, and thus increased ventilation to achieve a given workload. 7 Patients with CF may, therefore, have a higher V E due to the presence of an increasing physiological dead space on exercise, which increases with disease severity. 8 These factors, when combined together can lead to ventilatory limitation on exercise in subjects with CF.
Cardiopulmonary exercise testing (CPET) is considered the gold standard for the assessment of physical fitness in patients with CF. 9 The most commonly reported parameter of aerobic exercise capacity is the peak oxygen uptake (VO 2 peak), defined as the highest VO 2 attained during a single test. 10 However, other variables derived from CPET, including V E on exercise, and the peak ventilatory equivalent ratios for VO 2 (V E / VO 2 ) and carbon dioxide production (V E /VCO 2 ), are important to evaluate ventilatory efficiency during exercise, 11 while submaximal exercise data, for example, parameters measured at a subject's ventilatory threshold (VT) are also very valuable in assessing levels of conditioning. 12 VT is the point at which ventilation increases at a faster rate than VO 2 and reflects the point at which anaerobic metabolism begins to predominate with exponentially increasing VCO 2 and accumulation of fatigue-related metabolites including lactate. These effects on musculoskeletal and respiratory mechanisms serve to limit exercise capacity after VT. Due to the volitional aspects of all exercise tests, there may be an argument that measures at VT are more reproducible than peak data. Finally, significant associations have been reported between exercise capacity and life expectancy in patients with CF. [13] [14] [15] [16] [17] CPET provides detailed information on the performance of a patient's lungs in combination with cardiovascular and muscle systems, such that the test is an excellent way of monitoring clinical status and assessing response to disease and treatment.
Original article Figure 1 Flow chart of study design. ACT, AD, autogenic drainage; CPET, cardiopulmonary exercise testing; PEP, positive expiratory pressure.
Figure 2
Order of ACT/placebo and tests. ACT, airway clearance technique; CPET, cardiopulmonary exercise testing.
When considering the pathophysiology of lung disease in CF, chest physiotherapy plays an important part in patient care. 18 Putative goals of airway clearance techniques (ACTs) are to decrease airway obstruction and airflow limitation and to improve ventilatory distribution as a result of mobilisation and removal of airway mucus. 19 Moreover, ACT prevents premature airway closure, contributing to a reduction in air entrapment in the lung which minimises the development of dynamic hyperinflation. 20 There are several techniques that can be used, including positive expiratory pressure (PEP) and autogenic drainage (AD). 18 21 Given the mechanisms by which mucus retention within airways may lead to partial airway obstruction and increased dead space in those with CF, and the fact that dead space may be further impacted by dynamic hyperinflation on exercise, we hypothesise that the undertaking of ACT immediately prior to exercise may decrease airflow obstruction and enhance exercise performance. Thus, the aim of present study was to investigate whether the undertaking of ACT prior to CPET results in improvements in exercise capacity. A better understanding of how ACTs may influence exercise performance can potentially contribute to the daily life therapeutic management of patients with CF.
MeThOds
A prospective randomised, cross-over pilot study was performed on children aged >9 years and >128 cm tall who were attending CF clinic at the Royal Hospital for Sick Children, Edinburgh, UK. Patients who were chronically infected with Burkholderia cepacia and/or Mycobacterium abscessus were excluded due to infection control considerations. Children and adolescents were not recruited to the study at times of CF chest exacerbation, but could later be approached at a time of stability. Data were collected from January 2015 to October 2016. Assent was obtained from each participant along with informed consent from their parents.
study design
Two CPET tests were performed 1 month apart-one with ACT prior to CPET and the other without. Following recruitment and consent, subjects attended at least 4 weeks prior to the first CPET. Standardised ACT with PEP mask and AD was taught to all participants. Test 1 was performed after 4 weeks of regular use of ACT with the standardised technique. Test 2 was undertaken after a further 4 weeks of regular use of ACT with the standardised technique. The 4-week period was chosen to fit with scheduled clinic visits.
Subjects were allocated randomly, by sealed envelope, to one of two orders of testing: (1) ACT performed prior to first exercise test with no ACT undertaken prior to second test and (2) ACT performed prior to second exercise test with no ACT undertaken prior to first test. The study design is shown in figure 1 .
At each visit, subjects first had an appointment with a physiotherapist (30 min) during which they would either have an ACT session or a 30 min social conversation. The physiotherapy appointment would be immediately followed by an appointment with the respiratory physiology department (60 min) where spirometry followed by body plethysmography, and then CPET would be performed. The schedule used at each visit is shown in figure 2 .
The staff who supervised the CPET and analysed test data were blinded as to whether subject had undergone airway clearance physiotherapy before the test.
Anthropometric measures
Body mass and body height were determined using an electronic scale (Weymed, 500 series; H Faraday, London, England, UK) and a stadiometer (Harpenden Stadiometer; Holtain, Crymych, Wales, UK), respectively, in triplicate or until two identical values. Body mass index (BMI) was calculated as the body mass in kilograms divided by the square of the body height in metres. Data were converted to SD scores (z-scores) using the program WHO Anthroplus.
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Airway clearance physiotherapy
Airway clearance physiotherapy was carried out using the PEP mask (Astra Medical) along with AD techniques. Participants were instructed to sit with back straight, and elbows resting on a table. They were instructed to perform gentle, relaxed breathing at tidal volume using abdominal breathing for approximately five breaths or until breathing appeared relaxed. They were asked to hold the mask tight against face with both hands and inspire with a normal sized breath (using abdominal breathing) through the mask. AD breathing was performed with the PEP mask in place ensuring each participant expired down to low lung volumes and gradually moved through the three-phased breathing regimen using high expiratory flow rates at varying lung volumes to facilitate mucus clearance. [23] [24] [25] They were told that expiration should be slightly active (not forced) against the mask to create a back pressure of between 10 and 15 cmH 2 O measured by manometer (Wells Pct Healthcare, Sweden). 26 This was repeated for 15 breaths. The mask was then removed from the face and the participant was instructed to perform 1-2 huffs followed by a cough. This procedure was to be repeated four times.
Lung function
Spirometry was performed (Jaeger Masterscreen PFT Pro) prior to each exercise test. Three technically acceptable manoeuvres were performed and forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC) and forced expiratory flow between 25% and 75% of FVC (FEF 25%-75% ) were recorded in accordance of the joint American Thoracic Society and European Respiratory Society (ATS/ERS) standards for spirometry. 27 Lung function values were expressed as z-scores using appropriate reference data. 28 Whole-body plethysmography was performed also (Jaeger Masterscreen PFT Pro) enabling measurement of total lung capacity (TLC), residual volume (RV) and calculation of RV/ TLC ratio. 29 Tests were performed, and criteria of acceptability and reproducibility were applied in accordance with ATS/ERS guidelines. 30 Whole-body plethysmography values were also expressed as z-scores. 29 
Cardiopulmonary exercise testing
Subjects performed CPET on an electromagnetically braked cycle ergometer (Ergoline Viasprint 200; Ergoline, Blitz, Germany) using a modified version of the Godfrey protocol. 7 Subjects breathed into a full face mask connected to a pneumotachograph and sampling lines, using a calibrated metabolic cart (CareFusion UK, Basingstoke, England). Seat and handlebar height were identical for each test. A mask of known dead space was used (Carefusion 7400 and 8900), with the same mask used for both tests by each subject.
Breath-by-breath measurements of VO 2 , VCO 2 , V E and respiratory exchange ratio (RER) were made. Heart rate (HR) was also monitored continuously by a 12-lead ECG; blood pressure was measured every 1-2 min at rest, throughout the test and during active recovery; and transcutaneous oxygen saturation (SpO2%) was measured by a pulse oximeter placed on the right ear or on the index finger. Exercise was undertaken with a steadily increasing workload. Work rate was increased minute-by-minute by 10 W, 15 W or 20 W maintaining cadence at 65 rpm. 7 The following criteria were used to assess whether an exercise test had been 'maximal', namely: (1) a maximal HR similar to the theoretically predicted maximal value, that is, >85% of the participant's predicted maximal HR, where predicted maximal HR is calculated as 210− (0.65*age) 31 ; (2) a peak V E close to the predicted target 32 ; (3) a plateau in VO 2 despite an increasing workload (ie, final increase in VO 2 <200 mL/min for an increase in work of 5% to 10%); (4) RER>1.03 9 and (5) an inability of the participant to maintain cadence despite encouragement. At the beginning of the CPET and at the end, subjects were asked to classify the subjective degree of dyspnoea using the modified Borg scale. Peak aerobic capacity was calculated as the VO 2peak over the last 30 s of the test and was expressed corrected for body weight (mL/kg/min). Additional variables of interest from the CPET including the V E /VO 2 and V E /VCO 2 were also calculated. CPET variables data were presented at VT and at peak exercise. VT occurs at a point where V E /VO 2 begins to rise , while V E /VCO 2 is either falling or has reached a plateau. Breathing reserve was included and defined as BR=maximal voluntary ventilation (MVV)−V Epeak /MVV×100, where MVV was estimated using the 2003 prediction equations of Stein and colleagues. 32 
statistical analyses
Data normality was assessed by the Shapiro-Wilk test, and since they presented a normal distribution, continuous variables were presented as mean and SD. Categorical variables were presented in absolute and percentage frequencies. Paired t-tests were used to compare variables between tests. All analyses and data processing were performed via SPSS program version 18.0 (SPSS). In all cases, differences were considered significant when p≤0.05.
resuLTs
Eighteen subjects were recruited to the study. However, four subjects dropped out before the first test of the study and two patients were unable to adequately perform CPET (data unreportable). A total of 12 patients (6 boys/6 girls) completed the study with a mean age of 12.8±1.9 years. 75% (nine) of the patients presented at least one allele F508del. Table 1 characterises the study subjects. Table 2 displays pulmonary function data with and without ACT having been performed before the tests. In general, results were within or close to the limits of normality. No significant differences were found with regard to whether physiotherapy had been performed prior to spirometry. There was, however, a significant difference in mean (SD) functional residual capacity (FRC) z-score with ACT prior to plethysmography 0.12 (0.53) compared with −0.23 (0.70) without ACT (p=0.01).
Variables evaluated at peak exercise and at VT during CPET are shown in table 3. No significant difference in peak VO 2 was found between the tests. Mean(SD) VO 2peak with ACT prior to Finally, no statistically significant differences were found in MVV and BR when ACT was undertaken prior to CPET. Mean (SD) MVV with ACT was 96.15 (23.38) and without was 94.23 (26.94) (p=0.30). In addition, mean (SD) BR at VT with physiotherapy was 71.5 (4.98) and without was 69.16 (5.92) (p=0.10), and at peak exercise with ACT was 26.50 (12.85) and without was 24.08 (14.34) (p=0.62).
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dIsCussIOn
The study is a proof of concept study, demonstrating the potential for ACT techniques prior to exercise to improve exercise performance. Rather like the administration of a bronchodilator to an asthmatic shortly before exercise, this study provides physiological evidence that ACT may improve ventilatory efficiency during exercise in individuals with CF.
A higher FRC is noted in the group who have undertaken ACT prior to plethysmography. It is known that positive end expiratory pressure can distend airways and increase FRC, with potential alterations in lung compliance and ventilation/perfusion matching, 33 while Van der Schans and colleagues 34 have reported a significant increase in FRC during the use of PEP physiotherapy. An altered breathing pattern, with decreased expiratory flow and an increased expiratory time, leading to a reduced exhaled volume may be one explanation of why FRC increases. 35 The finding of higher FRC with prior ACT in this study may provide some supportive evidence for ACT using PEP and AD having similar effects on lung dynamics.
Differences in exercise physiology in subjects with CF are well-described. 36 Studies have demonstrated that V E in exercising subjects with CF is elevated to levels above that expected in healthy individuals 32 37 38 such that exercising subjects with CF may have reduced breathing reserve at the end of exercise. The altered ventilatory mechanics are reported to reflect the increased dead space caused by limitations in airflow and tend to parallel disease severity. 8 38 In addition, ventilatory equivalents (V E /VO 2 and V E /VCO 2 ) are also indicators of dead space ventilation and are indices of ventilatory efficiency. 11 The reduction in V E at VT when ACT was undertaken prior to exercise may suggest improved ventilatory mechanics following ACT. Furthermore, the lower ventilatory equivalent (V E /VO 2 and V E /VCO 2 ) measures at VT noted when ACT was undertaken prior to exercise suggests improved ventilatory efficiency with a lower V E per unit of oxygen consumed and carbon dioxide eliminated when compared to performing CPET without prior ACT. Mechanisms for lower V E /VO 2 and V E /VCO 2 measures could include relief of mucus obstruction and/or reduction in dynamic hyperinflation on exercise, each plausible as being directly impacted by ACT.
There are few valid, reliable and responsive outcome measures to evaluate airway clearance interventions in CF. Many patients have normal chest X-rays, clinical scores and exercise tests; moreover, some patients do not produce sputum, making it more difficult to assess changes after an intervention. While the choice of outcome measure would depend on the question being asked, commonly used outcomes in studies of airway clearance have included spirometry as well as sputum volume and weight. 39 40 Further research to identify appropriate outcome measures to evaluate airway clearance interventions appears warranted, and to our knowledge, this is the first study demonstrating that a session of physiotherapy can improve ventilatory dynamics during exercise in patients with CF. These data may support further work to establish the utility of CPET to measure response to change or intervention in CF.
It is perhaps unsurprising that no differences at peak exercise were noted, for VO 2peak is a global measure of fitness that assimilates the interaction of lungs, cardiovascular system and also skeletal muscle conditioning. 41 Thus, a single session of physiotherapy although it might improve ventilatory dynamics and allow for an improved training response, would be unlikely to alter VO 2peak . The ongoing use of ACT prior to physiotherapy as part of a training programme may however be associated with improvements in conditioning, and thus may impact peak exercise measures over time. Such a hypothesis would be worthy of consideration to test in future studies.
It is known that exercising around VT promotes a subject's endurance, improves conditioning and improves exercise performance. 12 Aerobic exercise programmes in CF that are designed to achieve a HR and/or VO 2 similar to that measured at VT are reported in published exercise training studies; for example, the Mukotrain study. 42 Therefore, by reducing V E and improving ventilatory efficiency around VT, improvements in training and conditioning ability may ensue that provide advantageous exercise adaptation.
There are study limitations that are important to note. First, the small sample size makes it difficult to generalise the results of this study, and it is important to interpret the findings of our pilot study with caution. The sample size was limited by the study being undertaken in a single-centre and requiring children to be old enough to reliably perform CPET. Second, we cannot evaluate the effect size of the physiotherapy because it was impossible for subjects to perform two maximal tests on the same day, with between test differences being confounded by the biological variability of the test itself. Furthermore, the fact that exercise itself promotes airway clearance would make it invalid to test our hypothesis with a second test on the same day. Finally, it remains to be further tested whether the significant differences in ventilatory dynamics that are reported at VT are of clinical significance and whether they can be successfully exploited by incorporating ACT into exercise training programmes for individuals with CF. Future study designs should aim to also include endurance tests to assess whether greater workloads and exercise durations are achieved when combining ACT with exercise training. Future study designs should aim to also include endurance tests to assess whether greater workloads and exercise durations are achieved when combining ACT with exercise training.
COnCLusIOn
These pilot data suggest that ACT prior to exercise may alter ventilatory mechanics and improve ventilatory efficiency in exercising patients with CF. These are potentially favourable adaptations to exercise training for individuals with CF and are worthy of further exploration in larger, longitudinal studies.
